SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (120)7/17/2000 1:00:06 PM
From: Jim Oravetz  Read Replies (1) of 164
 
E. coli's Death Grip on Intestinal Cells
July 6, 2000

CHEVY CHASE, MD---A team of researchers has produced the first detailed picture showing how pathogenic E. coli bacteria achieve a molecular death grip on intestinal cells. The structure may reveal critical steps in E. coli attachment that scientists can attack with drugs designed to thwart infection by halting bacterial binding. The E. coli bacteria include the enteropathogenic strains that are a major cause of childhood diarrhea in developing countries, killing close to one million children each year due to dehydration and other complications. This family of pathogens also includes E. coli O157:H7, a closely related strain that contaminates hamburger and other foods. E. coli O157:H7 causes at least 20,000 cases of bloody diarrhea and more than 200 deaths annually in the United States due to kidney failure, especially in young children and the elderly.

© 2000 Mediconsult.com. All rights reserved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News